Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actparin vs Heparin Sodium in Chronic Renal Failure
NCT01346215Phase 3Unknown
- Sponsor
- Bergamo
- Start
- Oct 2011
- Primary completion
- Dec 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of heparin in chronic kidney disease (CKD), sponsored by Bergamo. Primary endpoint: Effectiveness in prevention of clotting in the extracorporeal circuit during hemodialysis at 4 weeks. Status: unknown.
02
Drugs
heparin
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01346215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346215.